Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Cui W, Hao Y, Wang M, Zhang Q, Wang J, Wei G, Hou Y, Saretzki G. Inhibition of Autophagy Facilitates XY03-EA-Mediated Neuroprotection against the Cerebral Ischemia/Reperfusion Injury in Rats. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [PMID: 35401933 PMCID: PMC8986424 DOI: 10.1155/2022/7013299] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Accepted: 03/04/2022] [Indexed: 12/22/2022]

For:	Cui W, Hao Y, Wang M, Zhang Q, Wang J, Wei G, Hou Y, Saretzki G. Inhibition of Autophagy Facilitates XY03-EA-Mediated Neuroprotection against the Cerebral Ischemia/Reperfusion Injury in Rats. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [PMID: 35401933 PMCID: PMC8986424 DOI: 10.1155/2022/7013299] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Accepted: 03/04/2022] [Indexed: 12/22/2022]

Number

Cited by Other Article(s)

Wang M, Li Q, Ren B, Hao D, Guo H, Yang L, Wang Z, Dai L. Ethanolic extract of Arctium lappa leaves alleviates cerebral ischemia reperfusion-induced inflammatory injury via HDAC9-mediated NF-κB pathway. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2024;129:155599. [PMID: 38669967 DOI: 10.1016/j.phymed.2024.155599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Revised: 03/18/2024] [Accepted: 04/06/2024] [Indexed: 04/28/2024]

Abstract

BACKGROUND

Ischemic stroke (IS) is a major cause of mortality and disability worldwide. Inflammatory response is crucial in the pathogenesis of tissue injury in cerebral infarction. Arctium lappa leaves are traditionally used to treat IS.

PURPOSES

To investigate the neuroprotective effects and molecular mechanisms of the ethanolic extract of A. lappa leaves (ALLEE) on cerebral ischemia-reperfusion (CIR).

METHODS

Middle cerebral artery obstruction reperfusion (MCAO/R) rats and an oxygen-glucose deprivation/reoxygenation (OGD/R) cell model were used to evaluate ALLEE pharmacodynamics. Various methods, including neurological function, 2,3,5-triphenyltetrazolium chloride, hematoxylin and eosin, and Nissl, enzyme-linked immunosorbent, and TdT-mediated dUTP nick-end labeling assays, were used to analyze the neuroprotective effects of ALLEE in vitro and in vivo. The major chemical components and potential target genes of ALLEE were screened using network pharmacology. Molecular docking, western blotting, and immunofluorescence analyses were performed to confirm the effectiveness of the targets in related pathways.

RESULTS

ALLEE exerted potent effects on the MCAO/R model by decreasing the neurological scores, infarct volumes, and pathological features (p < 0.01). Furthermore, network pharmacology results revealed that the treatment of IS with ALLEE involved the regulation of various inflammatory pathways, such as the tumor necrosis factor (TNF) and chemokine signaling pathways. ALLEE also played key roles in targeting key molecules, including nuclear factor (NF)-κBIA, NF-κB1, interleukin (IL)-6, TNF-α and IL1β, and regulating the histone deacetylase (HDAC)-9-mediated signaling pathway. In vivo and in vitro analyses revealed that ALLEE significantly regulated the NF-κB pathway, promoted the phosphorylation activation of NF-κB P65, IκB and IKK (p < 0.01 or p < 0.05), and decreased the expression levels of the inflammatory factors, IL-1β, IL-6 and TNF-α (p < 0.01). Moreover, ALLEE significantly decreased the expression of HDAC9 (p < 0.01) that is associated with inflammatory responses. However, HDAC9 overexpression partially reversed the neuroprotective effects of ALLEE and its suppressive effects on inflammation and phosphorylation of NF-κB (p < 0.01).

CONCLUSIONS

In conclusion, our results revealed that ALLEE ameliorates MCAO/R-induced experimental CIR by modulating inflammatory responses via the inhibition of HDAC9-mediated NF-κB pathway.

Collapse

Jiao YR, Chen KX, Tang X, Tang YL, Yang HL, Yin YL, Li CJ. Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications. Cell Death Dis 2024;15:271. [PMID: 38632264 PMCID: PMC11024187 DOI: 10.1038/s41419-024-06659-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Revised: 03/31/2024] [Accepted: 04/08/2024] [Indexed: 04/19/2024]

Jiang Z, Wei J, Liang J, Huang W, Ouyang F, Chen C, Li P, Cao S, Cai Y, Li J, Huang B, Zeng J, Chen Y. Dl-3-n-Butylphthalide Alleviates Secondary Brain Damage and Improves Working Memory After Stroke in Cynomolgus Monkeys. Stroke 2024;55:725-734. [PMID: 38406851 DOI: 10.1161/strokeaha.123.045037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Accepted: 01/17/2024] [Indexed: 02/27/2024]

Abstract

BACKGROUND

Remote secondary neurodegeneration is associated with poststroke cognitive impairment (PSCI). Dl-3-n-butylphthalide (NBP) improves PSCI clinically. However, whether it ameliorates PSCI by alleviating secondary neurodegeneration remains uncertain. Nonhuman primates provide more relevant models than rodents for human stroke and PSCI. This study investigated the effects of NBP on PSCI and secondary neurodegeneration in cynomolgus monkeys after permanent left middle cerebral artery occlusion (MCAO).

METHODS

Thirteen adult male cynomolgus monkeys were randomly assigned to sham (n=4), MCAO+placebo (n=5), and MCAO+NBP groups (n=4). The MCAO+placebo and MCAO+NBP groups received saline and NBP injections intravenously, respectively, starting at 6-hour postsurgery for 2 weeks, followed by soybean oil and NBP orally, respectively, for 10 weeks after MCAO. Infarct size was assessed at week 4 by magnetic resonance imaging. Working memory and executive function were evaluated dynamically using the delayed response task and object retrieval detour task, respectively. Neuron loss, glia proliferation, and neuroinflammation in the ipsilateral dorsal lateral prefrontal cortex, thalamus, and hippocampus were analyzed by immunostaining 12 weeks after MCAO.

RESULTS

Infarcts were located in the left middle cerebral artery region, apart from the ipsilateral dorsal lateral prefrontal cortex, thalamus, or hippocampus, with no significant difference between the MCAO+placebo and MCAO+NBP group. Higher success in delayed response task was achieved at weeks 4, 8, and 12 after NBP compared with placebo treatments (P<0.05), but not in the object retrieval detour task (all P>0.05). More neurons and less microglia, astrocytes, CD68-positive microglia, tumor necrosis factor-α, and inducible NO synthase were observed in the ipsilateral dorsal lateral prefrontal cortex and thalamus after 12 weeks of NBP treatment (P<0.05), but not in the hippocampus (P>0.05).

CONCLUSIONS

Our findings indicate that NBP improves working memory by alleviating remote secondary neurodegeneration and neuroinflammation in the ipsilateral dorsal lateral prefrontal cortex and thalamus after MCAO in cynomolgus monkeys.

Collapse

Affiliation(s)

Zimu Jiang Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Jiating Wei Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Jiahui Liang Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Weixian Huang Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Fubing Ouyang Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Chunyong Chen Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) Department of Neurology, The First Affiliated Hospital, Guangxi Medical University; Nanning, China (C.C., P.L., B.H.)
Pingping Li Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) Department of Neurology, The First Affiliated Hospital, Guangxi Medical University; Nanning, China (C.C., P.L., B.H.)
Suhan Cao Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Yuangui Cai Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Jianle Li Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Baozi Huang Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) Department of Neurology, The First Affiliated Hospital, Guangxi Medical University; Nanning, China (C.C., P.L., B.H.)
Jinsheng Zeng Department of Neurology (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z.), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)
Yicong Chen Section II, Department of Neurology and Stroke Center (Y. Chen), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen) National Key Clinical Department, Key Discipline of Neurology; Guangzhou, China (Z.J., J.W., J. Liang, W.H., F.O., C.C., P.L., S.C., Y. Cai, J. Li, B.H., J.Z., Y. Chen)

Collapse

Zhang Z, Zou Y, Song C, Cao K, Cai K, Chen S, Wu Y, Geng D, Sun G, Zhang N, Zhang X, Zhang Y, Sun Y, Zhang Y. Advances in the study of exosomes in cardiovascular diseases. J Adv Res 2023:S2090-1232(23)00402-2. [PMID: 38123019 DOI: 10.1016/j.jare.2023.12.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2023] [Revised: 12/15/2023] [Accepted: 12/16/2023] [Indexed: 12/23/2023] Open

Affiliation(s)

Zhaobo Zhang Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Yuanming Zou Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Chunyu Song Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Kexin Cao Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Kexin Cai Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Shuxian Chen Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Yanjiao Wu Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Danxi Geng Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China
Guozhe Sun Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China.
Naijin Zhang Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China; Institute of Health Sciences, China Medical University, 77 Puhe Road, Shenbei New District, Shenyang, 110122, Liaoning Province, People's Republic of China; Key Laboratory of Reproductive and Genetic Medicine, China Medical University, National Health Commission, 77 Puhe Road, Shenbei New District, Shenyang, 110122, Liaoning Province, People's Republic of China.
Xingang Zhang Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China.
Yixiao Zhang Department of Urology Surgery, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, 110004, Liaoning Province, People's Republic of China.
Yingxian Sun Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China; Institute of Health Sciences, China Medical University, 77 Puhe Road, Shenbei New District, Shenyang, 110122, Liaoning Province, People's Republic of China.
Ying Zhang Department of Cardiology, The First Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, People's Republic of China; Institute of Health Sciences, China Medical University, 77 Puhe Road, Shenbei New District, Shenyang, 110122, Liaoning Province, People's Republic of China.

Collapse

Yuan Y, Sheng P, Ma B, Xue B, Shen M, Zhang L, Li D, Hou J, Ren J, Liu J, Yan BC, Jiang Y. Elucidation of the mechanism of Yiqi Tongluo Granule against cerebral ischemia/reperfusion injury based on a combined strategy of network pharmacology, multi-omics and molecular biology. PHYTOMEDICINE : INTERNATIONAL JOURNAL OF PHYTOTHERAPY AND PHYTOPHARMACOLOGY 2023;118:154934. [PMID: 37393828 DOI: 10.1016/j.phymed.2023.154934] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 06/10/2023] [Accepted: 06/19/2023] [Indexed: 07/04/2023]

Affiliation(s)

Yue Yuan Institute for Chinese Materia Medica, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China; Beijing Key Laboratory of TCM Pharmacology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100730, China
Peng Sheng Department of Neurology, Medical College, Institute of Translational Medicine, Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State Administration of Traditional Chinese Medicine, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225001, China
Bo Ma Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Materia Medica, Beijing 100730, China
Bingjie Xue Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China
Mengmeng Shen Department of Neurology, Medical College, Institute of Translational Medicine, Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State Administration of Traditional Chinese Medicine, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225001, China
Ling Zhang Department of Neurology, Medical College, Institute of Translational Medicine, Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State Administration of Traditional Chinese Medicine, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225001, China
Dan Li Shineway Pharmaceutical Group Co., Ltd., Shijiazhuang 051430, China
Jincai Hou Shineway Pharmaceutical Group Co., Ltd., Shijiazhuang 051430, China
Junguo Ren Beijing Key Laboratory of TCM Pharmacology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100730, China
Jianxun Liu Beijing Key Laboratory of TCM Pharmacology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100730, China.
Bing Chun Yan Department of Neurology, Medical College, Institute of Translational Medicine, Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, The Key Laboratory of Syndrome Differentiation and Treatment of Gastric Cancer of the State Administration of Traditional Chinese Medicine, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou 225001, China.
Yunyao Jiang Institute for Chinese Materia Medica, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.

Collapse

Li Y, Hong Z, Li S, Xie S, Wang J, Wang J, Liu Y. Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors. DISEASE MARKERS 2023;2023:9969437. [PMID: 37082457 PMCID: PMC10113042 DOI: 10.1155/2023/9969437] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Accepted: 10/05/2022] [Indexed: 04/22/2023]

Abstract

Objective

To investigate the efficacy of butylphthalide combined with edaravone in the treatment of acute ischemic stroke and the effect on serum inflammatory factors.

Methods

One hundred and sixty patients with acute ischemic stroke who attended the neurovascular intervention department of our hospital from May 2020 to June 2022 were enrolled as study subjects for prospective analysis and were equally divided into a control group and an experimental group using the random number table method, with 80 cases in each group. The control group was treated with edaravone injection, while the experimental group was treated with butylphthalide combined with edaravone. The disease was recorded to compare the efficacy, erythrocyte sedimentation rate, homocysteine, serum inflammatory factors including tumor necrosis factor-α, C-reactive protein and interleukin-6 levels, and the incidence of adverse reactions between the two groups.

Results

The total effective rate of treatment in the experimental group was 90.0% (72/80), while that of the control group was 62.5% (50/80), the total effective rate of the experimental group was significantly higher than that of the control group, and the difference was statistically significant (P < 0.05). After treatment, the erythrocyte sedimentation rate, homocysteine level, and serum TNF-α, CRP, and IL-6 levels of patients in the experimental group improved compared with those before treatment, and the degree of improvement was better than that of the control group, and the difference was statistically significant (P < 0.05). After 3 months of treatment, a comparison of the incidence of adverse reactions in the two groups showed no statistically significant difference between the two groups (P > 0.05).

Conclusion

The treatment of acute ischemic stroke with butylphthalide combined with edaravone has positive significance in improving blood circulation regulation and serum inflammatory factor levels and is reliable and worthy of clinical promotion.

Collapse

Exosomes derived from human umbilical cord mesenchymal stem cells (HUCMSC-EXO) regulate autophagy through AMPK-ULK1 signaling pathway to ameliorate diabetic cardiomyopathy. Biochem Biophys Res Commun 2022;632:195-203. [PMID: 36240643 DOI: 10.1016/j.bbrc.2022.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 09/28/2022] [Accepted: 10/01/2022] [Indexed: 11/19/2022]